drugset / Trial / NCT02089061

Drug Interaction Statin

NCT02089061

Phase 1 Completed 26 enrolled Bristol-Myers Squibb
Non-randomizedParallel-groupOpen-label

Summary

This purpose of this study is to assess the effects of BMS-919373 on the single dose Pharmacokinetics (PK) of Rosuvastatin and Atorvastatin in healthy subjects.

Timeline

Start
2014-03
Primary completion
2014-05
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 40 mg Oral
Subject BMS-919373 Small molecule 30 mg
Subject Rosuvastatin Small molecule 10 mg Oral